Anna Plotka
Impact in
-
- PARP inhibition in cancer therapy
- Drug Transport and Resistance Mechanisms
-
- Pharmacogenetics and Drug Metabolism
Papers in
- Co-authors
- Melissa T. O’Gorman (7 shared papers)Diane Wang (5 shared papers)Tanja Alebić-Kolbah (5 shared papers)Christine W. Alvey (5 shared papers)Virginia Parks (5 shared papers)Alain A. Patat (4 shared papers)Haihong Shi (5 shared papers)Marci L. Chew (4 shared papers)
- Journals
- Alzheimer s & Dementia (6 papers)British Journal of Clinical Pharmacology (5 papers)Clinical Pharmacology & Therapeutics (5 papers)The Journal of Clinical Pharmacology (3 papers)Annals of Oncology (2 papers)
- Partner nations
- United StatesUnited KingdomFrance
In The Last Decade
Anna Plotka
46 papers receiving 433 citations
Peers
Comparison fields: 5 of 69
- Oncology 147
- Pharmacology 33
- Pharmaceutical Science 23
- Genetics 36
- Pediatrics, Perinatology and Child Health 56
Countries citing papers authored by Anna Plotka
This map shows the geographic impact of Anna Plotka's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anna Plotka with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anna Plotka more than expected).
Fields of papers citing papers by Anna Plotka
This network shows the impact of papers produced by Anna Plotka. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anna Plotka. The network helps show where Anna Plotka may publish in the future.
Co-authors
The 25 scholars most cited alongside Anna Plotka, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 48 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2017 | 64 | |
| 2 | 2007 | 29 | |
| 3 | 2017 | 28 | |
| 4 | 2014 | 25 | |
| 5 | 2009 | 23 | |
| 6 | 2019 | 22 | |
| 7 | 2014 | 22 | |
| 8 | 2015 | 20 | |
| 9 | 2016 | 19 | |
| 10 | 2019 | 19 | |
| 11 | 2013 | 17 | |
| 12 | 2023 | 12 | |
| 13 | 2017 | 12 | |
| 14 | 2020 | 11 | |
| 15 | 2024 | 10 | |
| 16 | 2021 | 9 | |
| 17 | 2023 | 8 | |
| 18 | 2022 | 8 | |
| 19 | 2019 | 8 | |
| 20 | 2013 | 7 |
About Anna Plotka
Anna Plotka is a scholar working on Oncology, Genetics, Pulmonary and Respiratory Medicine, Pharmacology and Pharmacology, having authored 48 papers that have together received 451 indexed citations. Recurring topics across this work include Advanced Breast Cancer Therapies (6 papers), PARP inhibition in cancer therapy (5 papers), Chemical synthesis and alkaloids (3 papers), Colorectal Cancer Treatments and Studies (3 papers), HER2/EGFR in Cancer Research (3 papers), Neuroendocrine Tumor Research Advances (3 papers), Chronic Lymphocytic Leukemia Research (3 papers) and Hemoglobinopathies and Related Disorders (3 papers). The work is most often cited by research in Oncology (147 citations), Pharmacology (33 citations), Pharmaceutical Science (23 citations), Genetics (36 citations) and Pediatrics, Perinatology and Child Health (56 citations). Anna Plotka has collaborated with scholars based in United States, United Kingdom and France. Frequent co-authors include Melissa T. O’Gorman, Diane Wang, Tanja Alebić-Kolbah, Christine W. Alvey, Virginia Parks, Alain A. Patat, Haihong Shi, Marci L. Chew, Joseph M. Scavone and Diane D. Wang. Their work appears in journals such as Alzheimer s & Dementia, British Journal of Clinical Pharmacology, Clinical Pharmacology & Therapeutics, The Journal of Clinical Pharmacology and Annals of Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.